Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562507/
https://www.ncbi.nlm.nih.gov/pubmed/34725217
http://dx.doi.org/10.1136/jitc-2021-003005corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562507/
https://www.ncbi.nlm.nih.gov/pubmed/34725217
http://dx.doi.org/10.1136/jitc-2021-003005corr1

Ejemplares similares